PR

Priya Ramkeval Pal

Active Director Director DIN 11717008
DIN 11717008 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Priya Ramkeval Pal

Data last updated:

Priya Ramkeval Pal is a Director at Ravexa Healthtech Private Limited (since 2026).

DIN 11717008
Primary Designation Director
First Appointment 14 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ravexa Healthtech Private Limited U62011MH2026PTC471473
Director14 May 20262026Active

Board colleagues of Priya Ramkeval Pal

NameDINCompanyDesignation
Rahul Shivprasad Pal11717009Ravexa Healthtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ravexa Healthtech Private Limited
Premium access

Shareholding and investment profile for Priya Ramkeval Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priya Ramkeval Pal

Priya Ramkeval Pal currently holds 1 directorship: Ravexa Healthtech Private Limited (Director, since 14 May 2026).

Priya Ramkeval Pal was first appointed on 14 May 2026 as Director at Ravexa Healthtech Private Limited.

The current boards of Priya Ramkeval Pal's companies include Rahul Shivprasad Pal (Ravexa Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available